Laura Gianellini

PHA-739358, a potent inhibitor of Aurora kinases with a selective target inhibition profile relevant to cancer

Patrizia Carpinelli, Roberta Ceruti, Maria Laura Giorgini et al. · Molecular Cancer Therapeutics · 2007 · 240 citations

Histone H3, Potent Inhibitor, Cancer Biology +16

Inhibition of protein–protein interactions: The discovery of druglike β‐catenin inhibitors by combining virtual and biophysical screening

Jean‐Yves Trosset, Claudio Dalvit, Stefan Knapp et al. · Proteins Structure Function and Bioinformatics · 2006 · 179 citations

Protein–protein Interactions, Drug Target, Biophysical Screening +19

PHA-680632, a Novel Aurora Kinase Inhibitor with Potent Antitumoral Activity

Chiara Soncini, Patrizia Carpinelli, Laura Gianellini et al. · Clinical Cancer Research · 2006 · 160 citations

NMS-P937, an Orally Available, Specific Small-Molecule Polo-like Kinase 1 Inhibitor with Antitumor Activity in Solid and Hematologic Malignancies

Barbara Valsasina, Italo Beria, Cristina Alli et al. · Molecular Cancer Therapeutics · 2012 · 119 citations · Full text

Bipolar Spindle Formation, Antitumor Activity, Cell Death +17

Phosphorylation of TCTP as a marker for polo-like kinase-1 activity in vivo.

Ulisse Cucchi, Laura Gianellini, Anna De Ponti et al. · PubMed · 2010 · 62 citations

Molecular Regulation, Cell Death, Pathology +21